McCormick & Company, Incorporated
48.12USD
-0.5900 (-1.21%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on MKC.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 6.4B | 6.7B | 6.7B | 6.8B | 7.9B | 8.2B |
| Q1 | 1.5B | 1.6B | 1.6B | 1.6B | 1.9B | 2.0B |
| Q2 | 1.5B | 1.7B | 1.6B | 1.7B | 1.9B | — |
| Q3 | 1.6B | 1.7B | 1.7B | 1.7B | 2.0B | — |
| Q4 | 1.7B* | 1.8B* | 1.8B* | 1.9B* | 2.1B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 2.52 | 2.52 | 2.92 | 2.93 | 3.09 | 3.22 |
| Q1 | .570 | .520 | .620 | .600 | 3.77 | .640 |
| Q2 | .440 | .560 | .680 | .650 | .560 | — |
| Q3 | .820 | .630 | .830 | .840 | .360 | — |
| Q4 | .687* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| .813* |
| .798* |
| .841* |
| .781 |
| — |
Debt level and coverage